jCyte have released additional preclinical data regarding jCell
jCyte have released additional preclinical data regarding jCell
Search
Search results
jCyte update
In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.
New Gene Insertion Therapy for Stargard Disease in Development
SalioGen Developing Novel Gene Insertion Therapy for Stargardt disease.
Retina UK’s Souper Tuesday
Be a souper-star and raise funds whilst having lunch for #TeamRetinaUK
Meet our Trustee: Lynda Cantor MBE, Hon President
Lynda Cantor was a founder member of the charity in 1975 and one of our original trustees
e-Newsletter September 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
A new approach to treating inherited sight loss
A new approach to treating inherited sight loss
From isolation to exploration: what you can do to build your confidence when travelling
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Encouraging results from ProQR USH2A clinical trial
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.